SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (65)7/7/2002 10:57:37 PM
From: bits  Read Replies (1) of 684
 
VPHN Market Capitalization $28.9M Total Cash (mrq) $213.9M

Looks interesting, but:

But they have has 418 people and 38.9 of current liabilities and 180.1 of long term debt. So their debt is more than their cash, they have no income and at a guess 418 people means their burn rate is something like 50 million just for the people. They have sales of 7 million a year. No wonder they are selling for 1.42.

With no sales, I usually determine how much money they have per employee. VPHN has $511,000 per employee. But then there is that $218 million in debt. Looks a little dangerious to me.

There short interest is very high, and the they have one strong sell recommendation.

Are they going to be making money in the next 2-4 years? Otherwise, won't they go broke?

Know nothing about the science, just looking at the balance sheet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News